Transformative Solutions to Streamline Development of Novel Radiopharmaceuticals
Bringing new imaging and therapeutic radiopharmaceuticals to the market is a complex and challenging process that requires strong non-clinical data to support Investigational New Drug (IND) and Clinical Trial Application (CTA).
Preclinical radiopharmaceutical development requires specific studies including:
- Primary Pharmacology
- Safety Pharmacology and Toxicology
- Radiochemistry and Immunoreactivity
- Animal Biodistribution and Dosimetry
Learn more about the importance of specific non-clinical studies that help streamline the development of your novel radiopharmaceutical by downloading the infographic.